Effects of Intravenous Infusion of Vepoloxamer on Left Ventricular Function in Dogs with Advanced Heart Failure

Cardiovascular Drugs and Therapy
Hani N SabbahMartin Emanuele

Abstract

Vepoloxamer (VEPO), a rheologic agent, repairs damaged cell membranes, thus inhibiting unregulated Ca2+ entry into cardiomyocytes. This study examined the effects of i.v. infusion of VEPO on LV function in dogs with coronary microembolization-induced heart failure (HF) (LV ejection fraction, EF ~ 30%). Thirty-five HF dogs were studied. Study 1: 21 of 35 dogs were randomized to 2-h infusion of VEPO at dose of 450 mg/kg (n = 7) or VEPO at 225 mg/kg (n = 7) or normal saline (control, n = 7). Hemodynamics were measured at 2 h, 24 h, 1 week, and 2 weeks after infusion. Study 2: 14 HF dogs were randomized to 2-h infusions of VEPO (450 mg/kg, n = 7) or normal saline (control, n = 7). Each dog received 2 infusions of VEPO or saline (pulsed therapy) 3 weeks apart and hemodynamics measured at 24 h, and 1, 2, and 3 weeks after each infusion. In both studies, the change between pre-infusion measures and measures at other time points (treatment effect, Δ) was calculated. Study 1: compared to pre-infusion, high dose VEPO increased LVEF by 11 ± 2% at 2 h, 8 ± 2% at 24 h (p < 0.05), 8 ± 2% at 1 week (p < 0.05), and 4 ± 2% at 2 weeks. LV EF also increased with low-dose VEPO but not with saline. Study 2: VEPO but not saline significantly increas...Continue Reading

References

May 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·R C LeeR L Wollmann
Jul 1, 1966·The American Journal of Cardiology·H T DodgeR R Hawley
Jun 7, 1995·Molecular and Cellular Biochemistry·H N SabbahS Goldstein
May 20, 1998·The Journal of Surgical Research·F A MerchantM Toner
Feb 28, 2002·Biophysical Journal·Stacey A MaskarinecKa Yee C Lee
Mar 19, 2002·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Sudhish MishraHani N Sabbah
Sep 5, 2002·Journal of Pharmaceutical Sciences·J Michael GrindelM Balasubramanian
Jan 18, 2005·American Journal of Physiology. Heart and Circulatory Physiology·Harjot K Saini, Naranjan S Dhalla
Jan 25, 2005·Journal of Neurotrauma·Gulyeter SerbestKenneth Barbee
Jul 19, 2005·Nature·Soichiro YasudaJoseph M Metzger
Dec 24, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Gulyeter SerbestKenneth Barbee
Mar 15, 2006·Annals of the New York Academy of Sciences·Richard A Steinhardt
Mar 15, 2006·Annals of the New York Academy of Sciences·Jayant AgarwalRaphael C Lee
Mar 7, 2007·Circulation·Shao-kui WeiMark C P Haigney
Feb 14, 2009·Journal of the American College of Cardiology·Mihai Gheorghiade, Peter S Pang
Mar 18, 2010·The Journal of Clinical Investigation·Dewayne TownsendJoseph M Metzger
Jan 11, 2011·American Journal of Physiology. Heart and Circulatory Physiology·Sharad RastogiHani N Sabbah
Jun 2, 2012·Journal of Cardiovascular Pharmacology·Elizabeth B JunemanSteven Goldman
Jan 3, 2013·The Journal of Clinical Investigation·Andrew R Marks

❮ Previous
Next ❯

Citations

Nov 6, 2020·Evidence-based Complementary and Alternative Medicine : ECAM·Xiaomin YangYong Wang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.